Germany | Bayern

Zurück zur Suche

Internationale Partnersuche

Innovation & Technologie Angebot

A French technology transfer office offers an innovative needle-free device for multiple injections of drugs

Country of Origin: France
Reference Number: TOFR20180920001
Publication Date: 25 October 2018

Summary

The French TTO (Technology Transfer Office) is acting on behalf of major hospital and research group of the Paris region that has designed and patented an innovative needle-free device for multiple injections of drugs.  The French public research centre is looking for interested medtech corporates or biotechnology companies for a technical cooperation or a license agreement.

Description

A French Technology Transfer Office (TTO) is acting on behalf a major hospital and research group in the Paris region that has designed an innovative needleless device for multiple injections of drugs.

* Market challenges :
Subcutaneous injection of drugs is a routine practice in medical settings (for short or long term treatments) and a key tool of public health programs such as vaccination campaigns.
The injection has got several drawbacks, mostly due to the use of a needle : poor compliance, risk of contamination, difficulty of self-administration.

* State of the art :
Needle-free gas or spring injection systems are not optimal because they are bulky and their reliability is limited by the inherent constraints of mechanical systems. Moreover, these devices are one-shot injection systems.

* Proposed technology :
The invention is a needle-free device for multiple injections of drugs that uses the piezoelectric effect. The system makes possible repeated injections of a wide variety of drugs. Moreover, the size of this new system is small and it is ergonomic. It can be connected to a computer or a data cloud that collects, manages and analyses the medical data related to the injection required by the treatment. It can thus be a key tool for personalized medicine (dosage, compliance, etc.).

*Partnership :
The partner sought could be a company interested in :
- a license agreement as the TTO is ready to negociate directly the patents rights for specific applications, or
- a technical cooperation agreement if the industrial application can benefit directly from the actual technology to develop an industrial prototype.

*Keywords :

#Needle-free injection
#Piezoelectric
#Internet of things
#Personalized medicine

Advantages and Innovations

The advantages of this new technology are:

• small footprint
• ergonomic
• connected
• reusable

Stage Of Development

Under development/lab tested

Stage Of Development Comment

The technology has been tested but remains as pre-proof of concept. Technical developpments have to be done in order to have a functional prototype.

Requested partner

The TTO is looking for an industrial partner for prototyping and commercializing the technology.

The partners sought could be medtech corporates or biotechnology companies interested in :
- a licencing agreement as the TTO is ready to negotiate directly the patents rights for specific applications.
- a technical cooperation. The eventual partner should have a clear industrial application in mind and a strong technical background to co-develop a prototype.

Kooperationsanfrage stellen